Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by kenner6959on Mar 10, 2009 1:40pm
472 Views
Post# 15833748

March 31st >>>

March 31st >>>The Company will tell you that they have been in touch with the FDA and they should hear something back from them by the end of this month. That when someone responds to the FDA over such an issue as this, that they take thirty days to respond. We are within the 30 days and the end of that would line up with the end of this month. Call the Company to confirm if you like. They are optimistic on the FDA outcome.

Also, true about Dundee. I have seen this before re accumulation and then a potential buy signal. Like I mentioned earlier, I believe there is more going on here then we realize.

Not concerned. Do your own DD....

Regards...
Bullboard Posts